Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RNA · NASDAQ · Pharmaceutical Preparations · No 10-K yet
Atrium Therapeutics (RNA) · oqro.io/stocks/RNA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$6.43−1.08 (−14.38%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
T. Rowe Price Associates, Inc. cut its RNA stake below 5% (3.7%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Sessa Capital IM, L.P. disclosed an increased position in RNA for Q2 2026Source